In a complementary analysis of the CREATE‐ECLA study that showed a lack of benefit from GIK infusion, Chaudhuri et al16 suggested that ≈18% in mortality could be reduced if GIK‐induced hyperglycemia was avoided by insulin therapy. Here, INS is linked to Hyperglycemia.